We are live on ! Find out more
NKGNW

NKGen Biotech, Inc. Warrants
NKGNW

Delisted

NKGNW was delisted on the 4th of March, 2025.

Back to rankings

27 hedge funds and large institutions have $4.43M invested in NKGen Biotech, Inc. Warrants in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

52% more capital invested

Capital invested by funds: $2.92M → $4.43M (+$1.51M)

17% more funds holding

Funds holding: 23 → 27 (+4)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
27
Holders Change
+4
Holders Change %
+17.39%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
–
Reduced
1
Closed
3
Calls
$56K
Puts
–
Net Calls
+$56K
Net Calls Change
+$34K

Top Buyers

Rank Fund Capital Flow
1
PC
Periscope Capital
Ontario, Canada
+$122K
2
KC
Kepos Capital
New York
+$107K
3
Bank of America
Bank of America
North Carolina
+$20.3K
4
CCM
CAAS Capital Management
New York
+$10.2K

Top Sellers

Rank Fund Capital Flow
1
AIMCA
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
-$46K
2
EAM
Exos Asset Management
New York
-$16K
3
EIP
Easterly Investment Partners
Massachusetts
-$12K
4
Walleye Capital
Walleye Capital
New York
-$293
Name Holding Trade Value Shares
Change 		Change in
Stake
AA
1
AQR Arbitrage
Connecticut
$1.26M – – –
RCM
2
Radcliffe Capital Management
Pennsylvania
$1.16M – – –
HCM
3
Highbridge Capital Management
New York
$369K – – –
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$209K – – –
PC
5
Periscope Capital
Ontario, Canada
$137K +$122K +119,800 New
DCM
6
Difesa Capital Management
New York
$126K +$112K +110,000 New
KC
7
Kepos Capital
New York
$121K +$107K +105,000 New
6CM
8
683 Capital Management
New York
$115K – – –
FTCM
9
Fir Tree Capital Management
New York
$115K – – –
SCC
10
Spring Creek Capital
Kansas
$106K – – –
Balyasny Asset Management
11
Balyasny Asset Management
Illinois
$92K – – –
TCA
12
Taconic Capital Advisors
New York
$81K – – –
SCM
13
Shaolin Capital Management
Florida
$70K – – –
PAMP
14
Polar Asset Management Partners
Ontario, Canada
$69K – – –
D.E. Shaw & Co
15
D.E. Shaw & Co
New York
$58K – – –
RCM
16
Rivernorth Capital Management
Florida
$46K – – –
JG
17
Jefferies Group
New York
$40.3K – – –
ACM
18
Atalaya Capital Management
New York
$35K – – –
CH
19
CVI Holdings
Delaware
$35K – – –
NRCM
20
Northern Right Capital Management
Connecticut
$35K – – –
SC
21
Sculptor Capital
New York
$24K – – –
GF
22
Gabelli Funds
New York
$23K – – –
Bank of America
23
Bank of America
North Carolina
$23K +$20.3K +20,000 New
VCIM
24
Velan Capital Investment Management
Georgia
$23K +$20.3K +20,000 New
GCIA
25
Gabelli & Co Investment Advisers
New York
$20K – – –
1
2

NKGNW Hedge Fund Activity: Q4 2021 in Review

27 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in NKGen Biotech, Inc. Warrants (NKGNW) for Q4 2021, worth a combined $4.43M — up 52% from $2.92M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new NKGNW positions and 3 closed out — a net gain of 4 holders — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Periscope Capital, opening a new position worth an estimated $122K. The largest seller was Alberta Investment Management Corp (AIMCo), exiting entirely with an estimated $46K sold.

  • 27 institutional investors held NKGen Biotech, Inc. Warrants (NKGNW) as of Q4 2021, up from 23 in Q3 2021.
  • Funds reported $4.43M of NKGen Biotech, Inc. Warrants stock for Q4 2021, up 52% quarter-over-quarter.
  • 7 funds opened new NKGen Biotech, Inc. Warrants positions in Q4 2021 and 3 closed out, a net change of +4 holders.
  • The largest NKGen Biotech, Inc. Warrants buyer in Q4 2021 was Periscope Capital, an estimated $122K added.
  • The largest NKGen Biotech, Inc. Warrants seller in Q4 2021 was Alberta Investment Management Corp (AIMCo), an estimated $46K sold.

Based on aggregated 13F filings for Q4 2021.